SAFETY OF SGLT2 INHIBITORS (SGLT2I) IN PEOPLE OVER 75 YEARS

被引：0
|
作者：
Marques Vidas, Maria [1 ]
Domenech, Ester [1 ]
Martin Testillano, Lucia [1 ]
Maroto, Alba [1 ]
Lopez, Paula [1 ]
Portoles, Jose' M. [1 ]
机构：
[1] Puerta de Hierro Univ Hosp, Dept Nephrol, Majadahonda, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO167
引用
收藏
页码：I104 / I104
页数：1
相关论文
共 50 条
  • [1] Cardiovascular safety of SGLT2 inhibitors
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2016, 5 (02): : 62 - 65
  • [2] An update on the safety of SGLT2 inhibitors
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (04) : 295 - 311
  • [3] Ketoacidosis with SGLT2 inhibitors in Denmark over 20 years
    Reactions Weekly, 2017, 1644 (1) : 11 - 11
  • [4] Class effects of SGLT2 inhibitors (SGLT2i) in the heart: SGLT2i inhibit NHE, reduce [Na+]c and activate vasorelaxation in isolated mouse cardiomyocytes/hearts
    Uthman, L.
    Baartscheer, A.
    Bleijlevens, B.
    Schumacher, C. A.
    Fiolet, J. W. T.
    Koeman, A.
    Hollmann, M. W.
    Weber, N. C.
    Coronel, R.
    Zuurbier, C. J.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 109 : 59 - 59
  • [5] A PATIENT WITH UNEXPLAINED ERYTHROCYTOSIS. IS THERE AN SGLT2 INHIBITOR (SGLT2I) ON THE MEDICATION LIST?
    Wagar, Danish
    Leehey, David
    Vellanki, Kavitha
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S62 - S62
  • [6] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [7] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [8] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [9] Efficacy and cardiovascular safety of SGLT2 Inhibitors
    Fernandez, Cornelius James
    Nevins, Abisha Graciano
    Nawaz, Shasta
    Nazir, Tahir
    Hanna, Fahmy W. F.
    CURRENT DRUG SAFETY, 2021, 16 (02) : 178 - 196
  • [10] SGLT2 Inhibitors and Safety in Older Patients
    Pollack, Rena
    Cahn, Avivit
    HEART FAILURE CLINICS, 2022, 18 (04) : 635 - 643
12345